2001

1. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors

   Journal of Pharmacology and Experimental Therapeutics, Vol. 297, Núm. 3, pp. 1106-1112